Providing Veterans Essential Medications Act

Bill Number

H.R. 1970

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Armed Forces and National Security

Status

Introduced

Latest Action

2025-03-27: Referred to the Subcommittee on Health.

Last Updated

2026-07-10T08:06:13Z

AI-Generated Summary

Purpose

The "Providing Veterans Essential Medications Act" (H.R. 1970) aims to ensure that veterans receiving nursing home care in State homes have access to expensive medications without financial burden on those facilities. It directs the Department of Veterans Affairs (VA) to cover the costs of certain high-cost drugs either by reimbursing State homes or directly providing the medications.

Key Provisions

• Reimbursement or Furnishing of Medications: The VA Secretary must, at the State home's choice, either reimburse the facility for "costly medications" provided to veterans or supply those medications directly.
• Definition of Costly Medication: A drug or medicine qualifies if its average wholesale price for a one-month supply, plus a 3% transaction fee, exceeds 8.5% of the VA's monthly payment to the State home for that veteran's care.
• Covered State Homes: Applies to State homes (facilities operated by states for veteran care) that provide nursing home services under a VA contract and administer such costly medications to eligible veterans.
• Integration with Existing Payments: This coverage is in addition to standard VA payments for nursing home care under Section 1745 of title 38, U.S. Code.

Significant Changes to Existing Law

• Amends Section 1745(a)(3) of title 38, U.S. Code, which previously outlined general payments to State homes for veteran care.
• Introduces a new subparagraph (B) for optional reimbursement or direct provision of costly medications, and subparagraph (C) defining key terms.
• Shifts from a flat payment structure to one that includes targeted coverage for high-cost drugs, ensuring State homes are not out-of-pocket for these expenses.

Potential Impacts

• On Government Agencies: The VA will face increased administrative responsibilities and potential higher costs for reimbursements or drug procurement, which could strain its budget but improve care consistency.
• On Citizens: Veterans in State nursing homes gain better access to essential, expensive medications without gaps in treatment, potentially improving health outcomes and reducing financial pressure on state facilities.
• On International Relations: No direct impact, as the bill focuses on domestic veteran care.

Main Stakeholders Affected

• Veterans: Primary beneficiaries, especially those needing costly long-term medications while in nursing home care.
• State Homes: Gain financial relief through reimbursements or direct supplies, enabling them to maintain services without absorbing high drug costs.
• Department of Veterans Affairs: Responsible for implementing reimbursements and ensuring compliance, affecting its operations and funding allocations.
• Taxpayers: Indirectly impacted through federal spending on VA programs.

Notable Legal, Constitutional, or Political Implications

• Legal: Expands VA obligations under title 38 without altering core eligibility for benefits; the 8.5% threshold provides a clear, measurable standard to avoid disputes over what qualifies as "costly."
• Constitutional: Aligns with Congress's authority to regulate veteran benefits (Article I, Section 8); no apparent conflicts with due process or equal protection, as it targets a specific veteran subgroup.
• Political: Supports bipartisan efforts to enhance veteran healthcare access, potentially influencing future VA funding debates by addressing gaps in state-federal partnerships; may set a precedent for covering emerging high-cost treatments in long-term care.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Miller-Meeks, Mariannette [R-IA-1]

Cosponsors (52)

Rep. Pappas, Chris [D-NH-1], Rep. Suozzi, Thomas R. [D-NY-3], Rep. Bergman, Jack [R-MI-1], Rep. LaLota, Nick [R-NY-1], Rep. Garbarino, Andrew R. [R-NY-2], Rep. Tlaib, Rashida [D-MI-12], Rep. Gillen, Laura [D-NY-4], Rep. Scholten, Hillary J. [D-MI-3], Rep. Rogers, Mike D. [R-AL-3], Rep. Davis, Donald G. [D-NC-1], Rep. Lawler, Michael [R-NY-17], Rep. Meeks, Gregory W. [D-NY-5], Rep. Bynum, Janelle S. [D-OR-5], Rep. Harder, Josh [D-CA-9], Rep. Nunn, Zachary [R-IA-3], Rep. Crow, Jason [D-CO-6], Rep. Owens, Burgess [R-UT-4], Rep. Golden, Jared F. [D-ME-2], Rep. Feenstra, Randy [R-IA-4], Rep. Kaptur, Marcy [D-OH-9], Rep. Hageman, Harriet M. [R-WY-At Large], Rep. Meng, Grace [D-NY-6], Rep. Barrett, Tom [R-MI-7], Rep. Pingree, Chellie [D-ME-1], Rescom. Hernández, Pablo Jose [D-PR-At Large], Rep. Magaziner, Seth [D-RI-2], Rep. Malliotakis, Nicole [R-NY-11], Rep. Stauber, Pete [R-MN-8], Rep. Conaway, Herbert C. [D-NJ-3], Rep. De La Cruz, Monica [R-TX-15], Rep. Balint, Becca [D-VT-At Large], Rep. Hinson, Ashley [R-IA-2], Rep. Vindman, Eugene Simon [D-VA-7], Rep. Strickland, Marilyn [D-WA-10], Rep. Lee, Susie [D-NV-3], Rep. McClain Delaney, April [D-MD-6], Rep. Mace, Nancy [R-SC-1], Rep. Kennedy, Mike [R-UT-3], Rep. Riley, Josh [D-NY-19], Rep. Goodlander, Maggie [D-NH-2], Rep. McClain, Lisa C. [R-MI-9], Rep. Letlow, Julia [R-LA-5], Del. King-Hinds, Kimberlyn [R-MP-At Large], Rep. Goldman, Daniel S. [D-NY-10], Rep. Bresnahan, Robert P. [R-PA-8], Rep. Kennedy, Timothy M. [D-NY-26], Rep. Kelly, Mike [R-PA-16], Rep. Joyce, John [R-PA-13], Rep. McDowell, Addison P. [R-NC-6], Rep. Hoyer, Steny H. [D-MD-5] and 2 more

Recent Actions

• 2025-03-27: Referred to the Subcommittee on Health.
• 2025-03-10: Referred to the House Committee on Veterans' Affairs.
• 2025-03-10: Introduced in House
• 2025-03-10: Introduced in House

Bill Versions

• Providing Veterans Essential Medications Act — issued 2025-03-10 — PDF (3 pages)